Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/721
Type: Artigo de periódico
Title: Skin and oral lesions associated to imatinib mesylate therapy
Author: BASSO, Fernanda Goncalves
BOER, Camila Cominato
CORREA, Maria Elvira Pizzigatti
TORREZAN, Marcia
CINTRA, Maria Leticia
MAGALHAES, Marina H. C. Gallottini de
SANTOS, Paulo da Silva
SOUZA, Carmino Antonio de
Abstract: Imatinib mesylate is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) throughout all the phases of the disease. In most cases, this drug is well tolerated; however, some cases experience side effects. Skin rashes and oral lesions are uncommon and appear to be dose-dependent. The authors report two cases of CML Ph(+) in chronic phase patients who presented skin and oral lesions probably induced by imatinib therapy.
Subject: Imatinib mesylate
Oral lesions
Skin lesions
Side effects
Country: Estados Unidos
Editor: SPRINGER
Rights: fechado
Identifier DOI: 10.1007/s00520-008-0536-8
Address: http://dx.doi.org/10.1007/s00520-008-0536-8
http://apps.isiknowledge.com/InboundService.do?Func=Frame&product=WOS&action=retrieve&SrcApp=EndNote&UT=000264183100018&Init=Yes&SrcAuth=ResearchSoft&mode=FullRecord
Date Issue: 2009
Appears in Collections:FCM - Artigos e Materiais de Revistas Científicas

Files in This Item:
File Description SizeFormat 
art_BASSO_Skin_and_oral_lesions_associated_to_imatinib_2009.pdfpublished version228.18 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.